Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future.

dc.contributor.author Muntasell i Castellví, Aura, 1972-ca
dc.contributor.author López-Botet, M. (Miguel)ca
dc.date.accessioned 2016-06-01T11:11:48Z
dc.date.issued 2016
dc.description.abstract The report by Curti et al. highlightsthe potential of NK cell-based adoptive cellular immunotherapy in oncology,currently boosted by advances in the knowledge on NK cell biology and in their ex-vivo GMP manipulation.Several issues deserve attention to fully achieve the translation of these advances to the clinic.ca
dc.format.mimetype application/pdfca
dc.identifier.citation Muntasell A, López-Botet M. Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future. Clin Cancer Res. 2016 Apr 15;22(8):1831-3. DOI: 10.1158/1078-0432.CCR-15-3168ca
dc.identifier.doi http://dx.doi.org/10.1158/1078-0432.CCR-15-3168
dc.identifier.issn 1078-0432
dc.identifier.uri http://hdl.handle.net/10230/26791
dc.language.iso engca
dc.publisher American Association for Cancer Researchca
dc.relation.ispartof Clinical Cancer Research. 2016 Apr 15;22(8):1831-3
dc.rights.accessRights info:eu-repo/semantics/openAccessca
dc.subject.other Leucèmia mieloide agudaca
dc.title Natural Killer Cell-Based Immunotherapy in Acute Myeloid Leukemia: Lessons for the Future.ca
dc.type info:eu-repo/semantics/articleca
dc.type.version info:eu-repo/semantics/acceptedVersionca

Col·leccions